BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27630338)

  • 1. The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma.
    Toyokawa G; Taguchi K; Edagawa M; Shimamatsu S; Toyozawa R; Nosaki K; Hirai F; Yamaguchi M; Shimokawa M; Seto T; Takenoyama M; Hamamoto R; Sugio K; Ichinose Y
    Anticancer Res; 2016 Sep; 36(9):4841-6. PubMed ID: 27630338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6.
    Toyokawa G; Cho HS; Iwai Y; Yoshimatsu M; Takawa M; Hayami S; Maejima K; Shimizu N; Tanaka H; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2051-61. PubMed ID: 21930796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.
    Chen L; Fu L; Kong X; Xu J; Wang Z; Ma X; Akiyama Y; Chen Y; Fang J
    Br J Cancer; 2014 Feb; 110(4):1014-26. PubMed ID: 24473398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone demethylase JMJD2B-mediated cell proliferation regulated by hypoxia and radiation in gastric cancer cell.
    Kim JG; Yi JM; Park SJ; Kim JS; Son TG; Yang K; Yoo MA; Heo K
    Biochim Biophys Acta; 2012; 1819(11-12):1200-7. PubMed ID: 23046878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer.
    Li W; Zhao L; Zang W; Liu Z; Chen L; Liu T; Xu D; Jia J
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):372-8. PubMed ID: 22133676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
    Ujiie H; Kato T; Lee D; Hu HP; Fujino K; Kaji M; Kaga K; Matsui Y; Yasufuku K
    Int J Oncol; 2017 Jun; 50(6):2154-2170. PubMed ID: 28498455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
    Fu LN; Wang YQ; Tan J; Xu J; Gao QY; Chen YX; Fang JY
    Oncogene; 2018 Jan; 37(3):389-402. PubMed ID: 28945223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.
    Tan J; Wang HL; Yang J; Liu QQ; Li CM; Wang YQ; Fu LN; Gao QY; Chen YX; Fang JY
    Theranostics; 2020; 10(13):5763-5777. PubMed ID: 32483417
    [No Abstract]   [Full Text] [Related]  

  • 9. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
    Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
    Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
    Zhao L; Li W; Zang W; Liu Z; Xu X; Yu H; Yang Q; Jia J
    Clin Cancer Res; 2013 Dec; 19(23):6419-29. PubMed ID: 24077348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancer.
    Liu Y; Zheng P; Liu Y; Ji T; Liu X; Yao S; Cheng X; Li Y; Chen L; Xiao Z; Zhou J; Li J
    Gut; 2013 Apr; 62(4):571-81. PubMed ID: 22345654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.
    Song Z; Yu X; Cheng G; Zhang Y
    J Transl Med; 2016 Jun; 14(1):188. PubMed ID: 27342566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of β2 Adrenergic Receptor Expression in Surgically Resected Pulmonary Pleomorphic Carcinoma.
    Kaira K; Kamiyoshihara M; Kawashima O; Endoh H; Imaizumi K; Sugano M; Tanaka S; Fujita A; Kogure Y; Shimizu A; Oyama T; Asao T; Shimizu K; Mogi A
    Anticancer Res; 2019 Jan; 39(1):395-403. PubMed ID: 30591486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.
    Li X; Dong S
    Med Oncol; 2015 Mar; 32(3):53. PubMed ID: 25636512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma.
    Zhang J; Ni SS; Zhao WL; Dong XC; Wang JL
    Tumour Biol; 2013 Aug; 34(4):2397-401. PubMed ID: 23595221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
    Li Y; Miao L; Yu M; Shi M; Wang Y; Yang J; Xiao Y; Cai H
    Int J Oncol; 2017 Jun; 50(6):1955-1964. PubMed ID: 28440399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JMJD2B as a potential diagnostic immunohistochemical marker for hepatocellular carcinoma: a tissue microarray-based study.
    Lu JW; Ho YJ; Lin LI; Huang YC; Yeh KT; Lin YH; Lin YM; Tzeng TY
    Acta Histochem; 2015 Jan; 117(1):14-9. PubMed ID: 25533242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-13 Augments Histone Demethylase JMJD2B/KDM4B Expression Levels, Activity, and Nuclear Translocation in Airway Fibroblasts in Asthma.
    Bajbouj K; Hachim MY; Ramakrishnan RK; Fazel H; Mustafa J; Alzaghari S; Eladl M; Shafarin J; Olivenstein R; Hamid Q
    J Immunol Res; 2021; 2021():6629844. PubMed ID: 33688506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.